The interplay between
nanotechnology and pathogens offers a new
quest to fight against human infections. Inspiring from their unique
thermal, magnetic, optical, or redox potentials, numerous nanomaterials
have been employed for bacterial theranostics. The past decade has
seen dramatic progress in the development of various nanoantimicrobials,
which demands more focus on their safety assessment. The present review
critically discusses the toxicity of nanoantimicrobials and the role
of key features, including composition, size, surface charge, loading
capability, hydrophobicity/philicity, precise release, and functionalization,
that can contribute to modulating the effects on microbes. Moreover,
how differences in microbe’s structure, biofilm formation,
persistence cells, and intracellular pathogens bestow resistance or
sensitivity toward nanoantimicrobials is broadly investigated. In
extension, the most important types of nanoantimicrobial with clinical
prospective and their safety assessment are summarized, and finally,
based on available evidence, an insight of the principles in designing
safer nanoantimicrobials for overcoming pathogens and future challenges
in the field is provided.